Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-049911
Filing Date
2015-08-14
Accepted
2015-08-14 16:36:19
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v417227_10q.htm 10-Q 399644
2 EXHIBIT 31.1 v417227_ex31-1.htm EX-31.1 7922
3 EXHIBIT 31.2 v417227_ex31-2.htm EX-31.2 8106
4 EXHIBIT 32.1 v417227_ex32-1.htm EX-32.1 4168
5 EXHIBIT 32.2 v417227_ex32-2.htm EX-32.2 3860
  Complete submission text file 0001144204-15-049911.txt   4228246

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ambs-20150630.xml EX-101.INS 917882
7 XBRL TAXONOMY EXTENSION SCHEMA ambs-20150630.xsd EX-101.SCH 48647
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ambs-20150630_cal.xml EX-101.CAL 37581
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ambs-20150630_def.xml EX-101.DEF 308774
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ambs-20150630_lab.xml EX-101.LAB 346309
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ambs-20150630_pre.xml EX-101.PRE 330791
Mailing Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Filer) CIK: 0001424812 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55016 | Film No.: 151056474
SIC: 2834 Pharmaceutical Preparations